Nav: Home

NHS bowel scope uptake boosted by a fifth when patients sent reassuring reminders

January 14, 2018

Bowel scope screening uptake increased by more than a fifth (21.5%) when people were sent additional reminders with a leaflet that addressed common concerns, according to a new study funded by Cancer Research UK.*

The NHS bowel scope screening programme is gradually being rolled out in England to men and women aged between 55 and 59, prior to the bowel screening programme offered at 60.** It is a one-off, preventative and diagnostic test where a tiny camera is inserted into the bowel allowing doctors to find and remove any small bowel growths, called polyps, which could eventually turn into cancer.

The reminder letters, sent one and two years after the initial invitation, allowed people to choose the time of their appointment and the gender of the doctor performing the test.

The researchers found that the main concerns about the test included embarrassment, pain and fear of harm to the bowel. The leaflet, created by the researchers from University College London (UCL) with help from the public, included patient testimonials and advice from a named and pictured local GP to address this.

An invitation with an NHS information booklet and an appointment time is sent to the NHS-registered population at 55 years old. It is up to the recipient to confirm and attend their appointment. At two weeks, there is a further reminder to confirm the appointment. Around 40% of people attend their appointments with this system.***

Dr Robert Kerrison, lead researcher from University College London said: "Despite bowel scope screening attendance being low where it has been rolled out so far, this research shows that more could be done to improve uptake. Providing information targeting the concerns of patients is one way to break down the barriers to bowel scope screening uptake."

Dr Jodie Moffat, Cancer Research UK's head of early diagnosis said: "Cancer screening offers a lot of potential for reducing the burden of cancer but there are harms as well as benefits, so it's important that people make their own decision about whether to take part or not. Studies such as this help us learn about the best way to provide information in a way that resonates with people and ensures we can minimise any unnecessary barriers to people taking part. To fully realise the potential of cancer screening we need a system that adopts research findings into practice and has enough of the right workforce to deliver what's needed."

Bowel cancer is the 4th most common cancer in the UK and over half of bowel cancer cases are diagnosed at a late stage in England****
-end-
The study is published today in the Annals of Behavioral Medicine.

For more information on bowel cancer visit: http://www.cancerresearchuk.org/about-cancer/bowel-cancer

Notes to editor:

*Kerrison et al. Use of two self-referral reminders and a theory-based leaflet to increase the uptake of flexible sigmoidoscopy in the English Bowel Scope Screening Programme: results from a randomised controlled trial in London. Annals of Behavioral Medicine

** From the age of 60, patients are invited to take part in the bowel cancer screening programme, which offers biennial faecal occult blood testing (FOBT) to men and women

***McGregor et al. Uptake of Bowel Scope (Flexible Sigmoidoscopy) Screening in the English National Programme: the first 14 months. Journal of Medical Screening

****http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer

About Cancer Research UK

* Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.

* Cancer Research UK's pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.

* Cancer Research UK receives no funding from the UK government for its life-saving research. Every step it makes towards beating cancer relies on vital donations from the public.

* Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double in the last 40 years.

* Today, 2 in 4 people survive their cancer for at least 10 years. Cancer Research UK's ambition is to accelerate progress so that by 2034, 3 in 4 people will survive their cancer for at least 10 years.

* Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.

* Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured.

For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit http://www.cancerresearchuk.org. Follow us on Twitter and Facebook.

Cancer Research UK

Related Cancer Articles:

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.
Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Debbie Millman: Designing Our Lives
From prehistoric cave art to today's social media feeds, to design is to be human. This hour, designer Debbie Millman guides us through a world made and remade–and helps us design our own paths.
Now Playing: Science for the People

#574 State of the Heart
This week we focus on heart disease, heart failure, what blood pressure is and why it's bad when it's high. Host Rachelle Saunders talks with physician, clinical researcher, and writer Haider Warraich about his book "State of the Heart: Exploring the History, Science, and Future of Cardiac Disease" and the ails of our hearts.
Now Playing: Radiolab

Insomnia Line
Coronasomnia is a not-so-surprising side-effect of the global pandemic. More and more of us are having trouble falling asleep. We wanted to find a way to get inside that nighttime world, to see why people are awake and what they are thinking about. So what'd Radiolab decide to do?  Open up the phone lines and talk to you. We created an insomnia hotline and on this week's experimental episode, we stayed up all night, taking hundreds of calls, spilling secrets, and at long last, watching the sunrise peek through.   This episode was produced by Lulu Miller with Rachael Cusick, Tracie Hunte, Tobin Low, Sarah Qari, Molly Webster, Pat Walters, Shima Oliaee, and Jonny Moens. Want more Radiolab in your life? Sign up for our newsletter! We share our latest favorites: articles, tv shows, funny Youtube videos, chocolate chip cookie recipes, and more. Support Radiolab by becoming a member today at Radiolab.org/donate.